Fairvalue-Calculator Fairvalue-Calculator
EN DE

IRADIMED CORPORATION (IRMD) Fair Value & Analysis

Healthcare · US · Market cap $1.2B

Price$92.36
Fair Value$33.92
Upside-63.3%
Quality95/100
Evidence: High Range $22.81 – $58.64

Fair value as of: Jun 24, 2026

Analysis

IRADIMED CORPORATION (IRMD) currently trades at $92.36, while our model-based Fair Value estimate is $33.92 — implying the stock looks roughly 63.3% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is he…

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABTT34) -20% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -27% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is IRADIMED CORPORATION (IRMD) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $33.92 versus a price of $92.36 — about −63% (overvalued). Model-based estimate, not financial advice.
What is the fair value of IRMD?
Our 21-model fair value for IRADIMED CORPORATION is $33.92 (as of Jun 24, 2026), built from audited fundamentals. The current price is $92.36.
What is the quality score of IRMD?
IRADIMED CORPORATION has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.